CG
The Carlyle Group Inc. 4.625% Subordinated Notes due 2061
CGABL · NASDAQ
$15.83 -0.31% (-$0.05)
1M -1.62%
Market Cap $5.69B
P/E Ratio 15.64x
Div. Yield 7.30%
ROE 5.11%
Bulios Fair Price
$12.79
19.2% downside
Current Price
$15.83
Undervalued Fair Value Overvalued
According to Bulios Fair Price, CGABL is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap P/E 15.64x
P/S 1.58x
P/B 0.79x
Growth
20 /100
Declining EPS growth 14.68%
Rev. growth 2.50%
Book val. growth 1.14%
Profitability
23 /100
Weak Net margin 10.08%
Op. margin 2.38%
Gross margin N/A
Quality
54 /100
Average ROE 5.11%
ROA 1.29%
Asset turnover 0.13x
Debt
100 /100
Low Current ratio 17.99x
Debt/Equity N/A
Int. coverage N/A
Stability
30 /100
Unstable Beta 0.79x
Rev. volatility 61.91%
Profitable years 2
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CGABL
Online
Sector
Financial Services
Industry
Asset Management
CEO
Harvey Mitchell Schwartz
Employees
2,500
Headquarters
Washington
Upcoming events
30 OCT
Ex-Dividend
Ex-dividend date
15 NOV
Dividend Payment
Payment date